NCT04192487View on ClinicalTrials.gov

Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

October 22, 2019

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
Acquired Immunodeficiency SyndromeHealthy VolunteersHIV/AIDSHIV DiarrheaHuman Immunodeficiency Virus
Interventions
DRUG

Crofelemer delayed-release tablets 125mg

1 crofelemer delayed-release tablet twice daily at least 8 hours apart for 30 days with or without meals.

Trial Locations (3)

92780

Orange County Research Center, Tustin

06615

Healthcare Advocates International, Stratford

01105

The Research Institute, Springfield

Sponsors
All Listed Sponsors
lead

Napo Pharmaceuticals, Inc.

INDUSTRY

NCT04192487 - Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea | Biotech Hunter | Biotech Hunter